Apple cider vinegar intake linked to reduction in anthropometric variables and improvement in blood glucose, triglyceride, cholesterol levels
WEDNESDAY, March 13, 2024 (HealthDay News) — For overweight and obese individuals, apple cider vinegar (ACV) consumption is associated with a significant reduction in anthropometric variables, as well as improvement in blood glucose triglyceride and cholesterol levels, according to a study published online March 12 in BMJ Nutrition, Prevention & Health.
Rony Abou-Khalil, Ph.D., from the Holy Spirit University of Kaslik in Jounieh, Lebanon, and colleagues examined the effects of ACV consumption on weight and blood glucose, triglyceride, and cholesterol levels in 120 individuals of the Lebanese population with overweight and obesity. Participants were randomly assigned to an intervention group receiving 5, 10, or 15 mL of ACV or a control group receiving a placebo during a 12-week period. At weeks 0, 4, 8, and 12, measurements of anthropometric parameters, fasting blood glucose, and triglyceride and cholesterol levels were taken.
The researchers observed associations for daily consumption of the three doses of ACV for four to 12 weeks with significant reductions in anthropometric variables (weight, body mass index, waist/hip circumferences, and body fat ratio), blood glucose, and triglyceride and cholesterol levels. During the 12 weeks of ACV intake, there were no significant risk factors observed.
“These results suggest that ACV might have potential benefits in improving metabolic parameters related to obesity and metabolic disorders in obese individuals,” the authors write. “The results may contribute to evidence-based recommendations for the use of ACV as a dietary intervention in the management of obesity.”
Time-Restricted Eating May Help Patients With Type 1 Diabetes
Calorie Restriction and Mediterranean-Style Diet Yield Similar Weight Loss
Strength Training May Cut GDM Risk in Pregnant Women With Overweight, Obesity
Most Metabolic and Bariatric Surgery Candidates Meet Criteria for Clinical Obesity
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths
Obesity Treatment for U.S. Adolescents and Young Adults Shifted Rapidly From 2022 to 2026
3.2 Percent Undergoing Bariatric Surgery Develop New Alcohol-Related Diagnosis
RYGB, Sleeve Gastrectomy Cost-Effective for Teens With Severe Obesity